ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00895713
Recruitment Status : Completed
First Posted : May 8, 2009
Last Update Posted : May 8, 2009
Sponsor:
Information provided by:
Grifols Biologicals Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2005
  Actual Study Completion Date : July 2005